INTRODUCTION
============

A number of epidemiologic studies have suggested that vitamin D deficiency is associated with an increased incidence of asthma symptoms.[@B1]-[@B3] Vitamin D deficiency was thought to be eradicated with the fortification of foods and the apparent disappearance of rickets. However, vitamin D deficiency has reappeared and is associated with many disorders.[@B4] Despite food fortification, multiple studies have shown that vitamin D deficiency is highly prevalent even in sun-replete areas of the world[@B5] and that vitamin D supplementation and fortification of foods in current doses are inadequate to prevent deficiency.[@B6]

The existence of associations of vitamin D with asthma and allergy remains uncertain. While some suggest that vitamin D may be protective through prenatal or postnatal exposure, others suggest that vitamin D supplementation may increase the risk of allergy.[@B7] Associations between serum vitamin D levels and asthma severity in children and lung function in adults have been reported.[@B8],[@B9] Higher maternal intake of vitamin D during pregnancy was associated with a decreased risk of recurrence of wheezing in young children.[@B7],[@B10] Ginde et al.[@B11] found an inverse association between serum vitamin D levels and recent upper respiratory tract infections, especially in chronic respiratory diseases such as asthma. On the other hand, a case-control study on adults found that serum vitamin D levels did not differ between asthmatic patients and controls.[@B12]

The present study examined the relationship of serum 25 hydroxy vitamin D3 levels with asthmatic state, pulmonary function measures, severity, and control of asthma.

MATERIALS AND METHODS
=====================

Study population
----------------

This cross-sectional study was carried out on 100 children aged 6 to 18 years who had been referred to the Motahari Clinic of Shiraz University of Medical Sciences in autumn, 2009. The subjects included 50 asthmatic patients (31 males, 19 females; mean age 9.31 years), who were diagnosed based on the following criteria: 1) symptoms of recurrent (i.e., more than two) episodes of wheezing, cough, shortness of breath, or a combination of these; and 2) documented reversibility with bronchodilators.[@B13] Fifty healthy controls (31 males, 19 females; mean age 10.7 years) without a history of any allergic disorders in the child or first-degree relatives were also examined. The two groups were matched for age and sex (31 males, 19 females, aged 6-18 years).

Participants who had a history of consumption of any supplements of vitamin D or drugs that modulate serum vitamin D levels, such as systemic glucocorticoids and anticonvulsants, and those who had chronic diseases were excluded.

A questionnaire completed through an interview included questions regarding age, sex, body mass index, and some outcome measures related to asthma and its severity.

Serum 25(OH) vitamin D levels
-----------------------------

Blood samples were collected during the examination and centrifuged, aliquoted, and frozen to -70℃ until required. Serum concentrations of 25(OH) D were assayed using an RIA kit (DRG, Marburg, Germany) after extraction with acetonitrile.

We compared serum vitamin D levels in the two groups (asthmatic and healthy controls). Additionally, we examined the relationship between vitamin D levels and the following outcomes: eosinophil count, baseline forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC, use of anti-inflammatory drugs in the previous year, any hospitalization or any unscheduled visits for asthma within the past year, and duration and severity of disease.

In a descriptive analysis, we categorized vitamin D levels as deficient (\<20 ng/mL), insufficient (≥20 and \<30 ng/mL), or sufficient (≥30 ng/mL).[@B4],[@B14]

Peripheral blood eosinophil count
---------------------------------

A peripheral smear was performed in asthmatic children, and after Wright staining, eosinophils were counted.

Pulmonary-function testing
--------------------------

In asthmatic subjects, spirometry was conducted with a spirometer (Jaeger, flow screen, Würzburg, Germany). The best FEV1, FVC, and FEV1/FVC values were selected for analysis.

Statistical analysis
--------------------

The data were statistically analyzed using Student\'s *t*-test, one way ANOVA, and chi-square (linear by linear correlation) tests, as applicable (with a preset probability of *P*\<0.05). Experimental results are presented as arithmetic mean±SD. Statistical tests were conducted using the SPSS software package, version 16 (SPSS Inc., Chicago, IL, USA) on a personal computer. Additionally, using simple, multiple, and logistic regression analysis, the simultaneous effects of confounding variables such as, age, sex, vitamin D levels, and body mass index (BMI) on the asthmatic state were measured. Normality assumptions of distributions were applicable based on the Kolmogorov-Smirnov test.

RESULTS
=======

In this study, 100 children were examined (50 asthmatic and 50 non asthmatic).

[Table 1](#T1){ref-type="table"} shows the characteristics of both non-asthmatic and asthmatic subjects and the differences between the two groups. Mean 25(OH) D levels in the non-asthmatic and asthmatic groups were 66.82 and 49.29, respectively; this difference was statistically significant ([Table 1](#T1){ref-type="table"}; *P*=0.001).

The characteristics of asthmatic participants were stratified according to vitamin D quartiles. As shown in [Table 2](#T2){ref-type="table"}, in asthmatic subjects, there were statistically significant differences between strata in terms of sex, BMI, and predicted FEV1 (*P*\<0.05). Female sex and lower predicted FEV1 were significant predictors of lower 25(OH) D levels. There were no other statistically significant differences among the quartiles (*P*\>0.05).

Categorization of vitamin D levels revealed no statistically significant association between levels of vitamin D and asthmatic state ([Table 3](#T3){ref-type="table"}; linear by linear association=2.82; *P*=0.094).

Univariate analysis of the relationship between asthmatic state and age, sex, and vitamin D showed that younger age and lower vitamin D levels were associated with significantly increased odds of asthmatic state (*P*\<0.05).

Multivariate analyses of the relationship between asthma and vitamin D levels with adjustment for age and sex were conducted. As shown in [Table 4](#T4){ref-type="table"}, after controlling for age and sex, a stronger relationship between vitamin D levels and asthmatic state can be seen compared with the univariate analysis. Thus, increased vitamin D levels were associated with a greater decrease in the probability of asthmatic state compared with the univariate analysis (odds ratio \[OR\]= 0.95 and 0.97).

Linear association between vitamin D levels and lung-function parameters revealed that the associations between vitamin D level and predicted FEV1 (R^2^=0.318; *P*=0.024) and FEV1/FVC (R^2^=0.315; *P*=0.026) were statistically significant and those with baseline FEV1 and baseline and predicted FVC were not (*P*\>0.05). The correlation between vitamin D levels and predicted FEV1 is shown in [Figure](#F1){ref-type="fig"}.

Linear association analysis between vitamin D levels and eosinophil counts and other outcomes (use of anti-inflammatory drugs in the previous year, any hospitalization or any unscheduled visits for asthma within the past year, and duration of disease) revealed no significant association (*P*\>0.05).

DISCUSSION
==========

Vitamin D is involved in the maintenance of immune homeostasis. It has an important role in innate immunity; particularly through the direct induction of antimicrobial peptide (cathelicidin) gene expression.[@B15],[@B16] Vitamin D promotes the induction of T regulatory cells, including the expression of inhibitory cytokines (IL-10 and TGFβ) and control of CD4-positive T lymphocytes (Th1 and Th2).[@B17],[@B18] Vitamin D may reverse resistance to glucocorticoids in steroid resistant asthma[@B19] and potentiate the effect of allergen immunotherapy.[@B20] Observational studies suggest that vitamin D deficiency increases the risk of respiratory infection, which may contribute to the incidence of wheezing illnesses in children and adults and cause asthma exacerbations.[@B21] Polymorphisms in the gene encoding the vitamin D receptor have been associated with asthma phenotypes in two studies.[@B22],[@B23] Additionally, some evidence has suggested the effects of vitamin D on lung growth and development in neonates[@B24] and also on lung function in adults.[@B9] For the reasons noted above, vitamin D may be related to asthma and its severity.

In this study, which was conducted based on the categorization of vitamin D levels, 4% of asthmatic subjects had serum vitamin D levels \<20 ng/mL (compared with 2% in the control group), 12% had levels of 20-30 ng/mL (compared with 2% in the control group), and overall, 16% had levels ≤30 ng/mL (compared with 4% in the control group; *P*=0.094), which was not a statistically significant association. Brehm et al.[@B8] found that 25% of asthmatic patients had serum vitamin D levels \<30 ng/mL, and 3.4 % had levels \<20 ng/mL. In this study, we compared serum 25(OH) D levels in asthmatic subjects with those in a healthy control group. Although we observed higher prevalence of vitamin D insufficiency and deficiency in asthmatic children, this difference was not statistically significant. However, in the univariate analysis, we found a strong inverse association between serum vitamin D levels and asthmatic state. Also, in the multivariate analysis, after controlling for age and sex, this relationship had increased compared to the univariate analysis (OR=0.95-0.97). Thus, our data confirm the presence of lower vitamin D levels among asthmatic patients.

In our study, linear association analysis of serum 25 (OH) D levels and measures of lung function revealed that the direct associations with predicted FEV1 (*P*=0.024) and also with FEV1/FVC (*P*=0.026) were statistically significant. These findings suggest the involvement of vitamin D in lung function and the development of airflow limitation. However, the studies by Brehm et al.[@B8] and Litonjua et al.[@B25] reported contradictory data. Vitamin D inhibits the formation of matrix metalloproteinase as well as fibroblast proliferation and influences collagen synthesis; these actions mean that 1,25-dihydroxy vitamin D may influence tissue remodeling and probably lung function.[@B26],[@B27] Black and Scragg[@B9] found that serum 25-OH vitamin D level was positively associated with FEV1 and FVC in the United States\' general population.

Brehm et al.[@B8] found an inverse relationship between circulating levels of vitamin D and several markers of allergy and asthma severity such as eosinophil count, IgE levels, asthma exacerbation, airway responsiveness, and skin-test reactivity. Litonjua et al.[@B25] found that children with insufficient levels of 25(OH) D were more likely to have severe exacerbations, but they did not find any association between vitamin D and bronchodilator response or airway hyperresponsiveness. In our study, there were no associations between vitamin D levels and eosinophil counts, course of disease, asthma exacerbation, or anti-inflammatory drug use. This may be due to the smaller number of subjects and unequal sex distribution in both groups.

A number of confounding factors may influence these relationships. One is that the subjects with asthma spend more time indoors, so they may be exposed to less sunlight.[@B2] However, we found a relationship between vitamin D and lung function outcomes that contribute to the severity of asthma, especially FEV1/FVC, which is a marker of airway obstruction. Another factor is the effects of other nutrients, such as vitamin E. Due to the strong evidence linking vitamin D deficiency to Th1 diseases, the role of vitamin E is likely weaker.[@B2]

Vitamin D deficiency is highly prevalent even in sun-replete areas of the world.[@B5] Some possible explanations include behavioral factors (e.g. sunscreen use, increased time spent indoors, and clothing coverage) and intrinsic factors such as skin melanin content, ethnicity (dark-skinned person), and decreased cutaneous production of vitamin D3.[@B28]

Although there is no consensus regarding optimal 25-hydroxy vitamin D serum levels, based on epidemiologic studies, a desirable level of serum vitamin D, i.e., 25(OH) D, for general health is at least 30 to 40 ng/mL (75 to 100 nmol/L).[@B4],[@B6] It has been suggested that levels higher than 40 ng/mL (100 nmol/L) may be necessary for optimal immune functioning and overall health.[@B29] It seems that current national recommendations of vitamin D (200-600 IU per day, depending on age) are insufficient to bring serum 25(OH)D levels to 75-100 nmol/mL, and, therefore, higher doses up to 700-1,000 IU per day may be necessary.[@B30]

In the present study, we found lower serum 25(OH) D levels in asthmatic children compared with controls, and we also found a direct relationship between serum 25(OH) D levels and lung-function measures. An interventional study in asthmatic patients with low serum vitamin D concentrations is now required to establish a causal relationship between asthma and vitamin D level.
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Characteristics of patients in asthmatic and non-asthmatic groups
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^\*^Two-sample *t*-test; ^†^Chi-square test.

BMI, body mass index.
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Characteristics of asthmatic patients
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^\*^One way ANOVA; ^†^linear by linear correlation (chi-square); ^‡^chi-square test.

BMI, body mass index; FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity.
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Vitamin D levels according to asthmatic state
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Chi-square value for linear by linear association=2.82; *P*=0.094.

###### 

Association between asthmatic state and age, sex, and Vitamin D levels in multivariate analysis^\*^
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^\*^BMI excluded from the model; ^†^male is the reference group.

OR, odds ratio; CI, confidence interval.
